Sponsor Pipeline

AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07053462 CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk End-Stage Renal Disease Recruiting
NCT07053488 CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection Liver Diseases Recruiting
Disease Areas
Get alerts when AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free